Susquehanna International Group, LLP Dyne Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2025 May 14, 2025	SELL	$10.46 - $25.46 $202,924 - $493,924	-19,400 Reduced 31.65%	41,900 $438,000
Q4 2024 Feb 14, 2025	SELL	$23.56 - $35.55 $2.44 Million - $3.68 Million	-103,600 Reduced 62.83%	61,300 $1.44 Million
Q3 2024 Nov 14, 2024	BUY	$31.94 - $47.04 $4.49 Million - $6.61 Million	140,600 Added 578.6%	164,900 $5.92 Million
Q2 2024 Aug 15, 2024	SELL	$23.65 - $35.63 $307,450 - $463,190	-13,000 Reduced 34.85%	24,300 $857,000
Q1 2024 May 07, 2024	BUY	$13.06 - $29.18 $206,348 - $461,044	15,800 Added 73.49%	37,300 $1.06 Million
Q4 2023 Feb 14, 2024	BUY	$6.62 - $13.64 $142,330 - $293,260	21,500 New	21,500 $285,000

217

127M

36.5K

138K

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $967M
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.